$25.05
▲ +$0.54
(+2.20%)
Vol 303K
7
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$1.2B
P/E
130.5
ROE
1.3%
Margin
0.3%
D/E
135.37
Beta
0.89
52W
$20–$40
Wall Street Consensus
17 analysts · Apr 20267
Strong Buy
7
Buy
3
Hold
0
Sell
0
Strong Sell
82.4%
Buy Rating
Price Chart
Similar Stocks
WGS
GeneDx Holdings Corp
P/E 1803.0
$3.8B
ADUS
Addus Homecare Corp
P/E 23.2
$2.0B
AVAH
Aveanna Healthcare Holdings Inc
P/E 22.6
$1.7B
NEO
Neogenomics Inc
$1.5B
INNV
InnovAge Holding Corp
$704.2M
PNTG
Pennant Group Inc
P/E 36.5
$973.8M
LMRI
Lumexa Imaging Holdings Inc
TALK
Talkspace Inc
P/E 141.8
$601.3M
OPK
OPKO Health Inc
$967.3M
Earnings
Beat rate: 25.0%
Next Report
May 06, 2026
EPS Estimate: $0.31
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $0.31 | — | — |
| Dec 2025 | $0.11 | $0.12 | +$0.01 |
| Sep 2025 | $0.45 | $0.01 | $-0.44 |
| Jun 2025 | $0.37 | $0.19 | $-0.18 |
Quarterly Revenue & Earnings
| Quarter | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|
| Revenue | $665.2M | $620.4M | $654.8M | $956.0M | $950.5M |
| Net Income | -$7.0M | $6.7M | $9.4M | $373K | $6.0M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | 3.5% | 3.5% | 3.5% | 3.5% | 1.3% | 1.3% |
| P/E (TTM) | 49.18 | 58.51 | 55.58 | 61.69 | 123.38 | 130.48 |
| Net Margin | 1.4% | 1.0% | 1.0% | 1.0% | 0.3% | 0.3% |
| Gross Margin | 11.9% | 11.3% | 11.3% | 11.3% | 10.2% | 10.2% |
| D/E Ratio | 54.03 | 54.03 | 54.03 | 54.03 | 135.37 | 135.37 |
| Current Ratio | 1.59 | 1.59 | 1.59 | 1.59 | 1.40 | 1.40 |
Key Ratios
ROA (TTM)
0.6%
P/S (TTM)
0.43
P/B
2.5
EPS (TTM)
$0.19
Rev Growth 3Y
+38.0%
52W High
$39.97
52W Low
$20.12
$20.12
52-Week Range
$39.97
Financial Health
Free Cash Flow
-$6.0M
Net Debt
$648.7M
Cash
$429.5M
Total Debt
$1.1B
As of Dec 31, 2025
How does ASTH compare to Health Care peers?
Peer group: Micro-cap Health Care (All) · 241 companies
ASTH valuation vs Health Care peers
P/E ratio
130.5
▲
325%
above
peers
(30.7)
vs Peers
vs Industry
Undervalued
P/S ratio
0.4
▼
83%
below
peers
(2.6)
vs Peers
vs Industry
Undervalued
P/B ratio
2.5
▼
10%
below
peers
(2.8)
vs Peers
vs Industry
Fair value
Div yield
—
▼
0%
below
peers
(0.7%)
vs Peers
vs Industry
Low yield
ASTH profitability vs Health Care peers
ROE
1.3%
▲
103%
above
peers
(-38.5%)
vs Peers
vs Industry
Top tier
Net margin
0.3%
▲
101%
above
peers
(-24.7%)
vs Peers
vs Industry
Below avg
Gross margin
10.3%
▼
81%
below
peers
(52.9%)
vs Peers
vs Industry
Weak
ROA
0.6%
▲
103%
above
peers
(-21.2%)
vs Peers
vs Industry
Top tier
ASTH financial health vs Health Care peers
D/E ratio
135.4
▲
602%
above
peers
(19.3)
vs Peers
vs Industry
High debt
Current ratio
1.4
▼
35%
below
peers
(2.2)
vs Peers
vs Industry
Low liquidity
Beta
0.9
▼
15%
below
peers
(1.1)
vs Peers
vs Industry
Less volatile
ASTH fundamentals radar
ASTH
Peer median
Industry
ASTH profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
ASTH vs peers: key metrics
Insider Activity
NeutralBuys
0
Sells
0
SIM BRANDON
Chief Executive Officer · Feb 02
21334 shs
SCHMIDT DAVID
Director · Jan 13
20000 shs
Last 90 days
Top Holders
Top 5: 42.26%Blackrock Inc.
17.20%
$149.0M
Vanguard Group Inc
11.84%
$102.5M
325 Capital Llc
5.14%
$44.5M
State Street Corporation
4.68%
$40.5M
Dimensional Fund Advisors LP
3.40%
$29.4M
As of Dec 31, 2025
Latest News
No related news yet